MedAI Verdict

AI Pathology

Ibex Medical Analytics review

Ibex Medical Analytics alternatives

13 tools that we compared head to head with Ibex Medical Analytics in a written verdict. Each row says who the tool suits, according to that verdict, and links to the full comparison.

The list is not a ranking. Tools in the same category come first, then every group is in alphabetical order. A tool that is no longer sold is left out.

  • aetherAI logo

    aetherAI

    Slide QC, cell counting and IHC quantification apps; viewer for primary diagnosis of FFPE slides

    See the review for plans

    Full comparison
  • Aiforia logo

    Aiforia

    CE-IVD prostate suite, IVDR reported February 2025; sOC 2 Type II and ISO 27001

    See the review for plans

    Full comparison
  • Artera logo

    Artera

    De Novo DEN240068 for prostate prognosis; 10-year metastasis risk, males 55 or older

    See the review for plans

    Full comparison
  • Caris Life Sciences logo

    Caris Life Sciences

    MI Clarity reads H&E, no sequencing; distant recurrence risk in early HR+/HER2- breast cancer

    See the review for plans

    Full comparison
  • Freenome logo

    Freenome

    PMA-approved colorectal blood test, ages 45 and older; abbott to commercialize from fall 2026, per release

    See the review for plans

    Full comparison
  • GRAIL logo

    GRAIL

    Vendor says Galleri detects 50+ cancer types; pMA under review, not approved

    See the review for plans

    Full comparison
  • Indica Labs HALO AI logo

    Indica Labs HALO AI

    HALO AP Dx cleared with two named scanners; hALO AI trains classifiers by example

    See the review for plans

    Full comparison
  • PathAI AISight logo

    PathAI AISight

    Cloud image management cleared for primary diagnosis; cE-IVD for EEA, UK and Switzerland

    See the review for plans

    Full comparison
  • Proscia Concentriq logo

    Proscia Concentriq

    Life Sciences line for biomarker research; two 510(k) records and SOC 2 Type II

    See the review for plans

    Full comparison
  • Sectra Pathology logo

    Sectra Pathology

    Viewer, worklists and reporting in one system; two FDA 510(k)s for the Digital Pathology Module

    See the review for plans

    Full comparison
  • Tempus Digital Pathology logo

    Tempus Digital Pathology

    De Novo DEN200080 since September 2021; fDA study with 16 pathologists

    See the review for plans

    Full comparison
  • Vesta logo

    Vesta

    BCGPredict targets BCG response in bladder cancer; risk Stratify scores recurrence and progression

    See the review for plans

    Full comparison
  • Visiopharm logo

    Visiopharm

    Vendor cites nine IVDR-certified diagnostic algorithms; hER2, ER, PR and Ki-67 scoring apps

    See the review for plans

    Full comparison

Read the Ibex Medical Analytics reviewAll pathology